Allogene Therapeutics, Inc. (ALLO)
2.58
-0.07
(-2.64%)
USD |
NASDAQ |
Mar 03, 11:31
Allogene Therapeutics EPS Diluted (Quarterly) : -0.1864 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.172 |
| Agenus, Inc. | 1.944 |
| Curis, Inc. | -0.4929 |
| LadRx Corp. | -1.453 |
| Plus Therapeutics, Inc. | -0.0412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -41.40M |
| Total Expenses (Quarterly) | 41.40M |
| Enterprise Value | 428.48M |
| Earnings Yield | -38.03% |
| Normalized Earnings Yield | -37.73 |